United States Wilson's Disease Treatment Market Report 2017

December 2017 | 95 pages | ID: UC4F36A6C96EN
QYResearch

Abstracts

In this report, the United States Wilson's Disease Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Wilson's Disease Treatment in these regions, from 2012 to 2022 (forecast).

United States Wilson's Disease Treatment market competition by top manufacturers/players, with Wilson's Disease Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Valeant Pharmaceuticals International. Inc.
• Tsumura & Co
• Merck & Co
• VHB Life Science Inc.
• Teva Pharmaceuticals USA, Inc
• Wilson's Therapeutics AB
• Noble Pharma Co., Ltd
• Kadmon Holding, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• D-Penicillamine
• Trientine
• Tetrathiomolybdate
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Wilson's Disease Treatment Market Report 2017

1 WILSON'S DISEASE TREATMENT OVERVIEW

1.1 Product Overview and Scope of Wilson's Disease Treatment
1.2 Classification of Wilson's Disease Treatment by Product Category
  1.2.1 United States Wilson's Disease Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Wilson's Disease Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 D-Penicillamine
  1.2.4 Trientine
  1.2.5 Tetrathiomolybdate
  1.2.6 Others
1.3 United States Wilson's Disease Treatment Market by Application/End Users
  1.3.1 United States Wilson's Disease Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Wilson's Disease Treatment Market by Region
  1.4.1 United States Wilson's Disease Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Wilson's Disease Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Wilson's Disease Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Wilson's Disease Treatment Status and Prospect (2012-2022)
  1.4.5 New England Wilson's Disease Treatment Status and Prospect (2012-2022)
  1.4.6 The South Wilson's Disease Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Wilson's Disease Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Wilson's Disease Treatment (2012-2022)
  1.5.1 United States Wilson's Disease Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Wilson's Disease Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES WILSON'S DISEASE TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Wilson's Disease Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Wilson's Disease Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Wilson's Disease Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Wilson's Disease Treatment Market Competitive Situation and Trends
  2.4.1 United States Wilson's Disease Treatment Market Concentration Rate
  2.4.2 United States Wilson's Disease Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Wilson's Disease Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES WILSON'S DISEASE TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Wilson's Disease Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Wilson's Disease Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Wilson's Disease Treatment Price by Region (2012-2017)

4 UNITED STATES WILSON'S DISEASE TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Wilson's Disease Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Wilson's Disease Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Wilson's Disease Treatment Price by Type (2012-2017)
4.4 United States Wilson's Disease Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES WILSON'S DISEASE TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Wilson's Disease Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Wilson's Disease Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES WILSON'S DISEASE TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Valeant Pharmaceuticals International. Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Tsumura & Co
  6.2.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Tsumura & Co Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck & Co
  6.3.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck & Co Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 VHB Life Science Inc.
  6.4.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 VHB Life Science Inc. Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Teva Pharmaceuticals USA, Inc
  6.5.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Wilson's Therapeutics AB
  6.6.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Wilson's Therapeutics AB Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Noble Pharma Co., Ltd
  6.7.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Noble Pharma Co., Ltd Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Kadmon Holding, Inc.
  6.8.2 Wilson's Disease Treatment Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Kadmon Holding, Inc. Wilson's Disease Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 WILSON'S DISEASE TREATMENT MANUFACTURING COST ANALYSIS

7.1 Wilson's Disease Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Wilson's Disease Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Wilson's Disease Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Wilson's Disease Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES WILSON'S DISEASE TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Wilson's Disease Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Wilson's Disease Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Wilson's Disease Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Wilson's Disease Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Wilson's Disease Treatment
Figure United States Wilson's Disease Treatment Market Size (K Pcs) by Type (2012-2022)
Figure United States Wilson's Disease Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure D-Penicillamine Product Picture
Figure Trientine Product Picture
Figure Tetrathiomolybdate Product Picture
Figure Others Product Picture
Figure United States Wilson's Disease Treatment Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Wilson's Disease Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Wilson's Disease Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Wilson's Disease Treatment Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Wilson's Disease Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Wilson's Disease Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Wilson's Disease Treatment Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Wilson's Disease Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Wilson's Disease Treatment Sales Share by Players/Suppliers
Figure 2017 United States Wilson's Disease Treatment Sales Share by Players/Suppliers
Figure United States Wilson's Disease Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Wilson's Disease Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Wilson's Disease Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Wilson's Disease Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Wilson's Disease Treatment Revenue Share by Players/Suppliers
Table United States Market Wilson's Disease Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Wilson's Disease Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Wilson's Disease Treatment Market Share of Top 3 Players/Suppliers
Figure United States Wilson's Disease Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Wilson's Disease Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Wilson's Disease Treatment Product Category
Table United States Wilson's Disease Treatment Sales (K Pcs) by Region (2012-2017)
Table United States Wilson's Disease Treatment Sales Share by Region (2012-2017)
Figure United States Wilson's Disease Treatment Sales Share by Region (2012-2017)
Figure United States Wilson's Disease Treatment Sales Market Share by Region in 2016
Table United States Wilson's Disease Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Wilson's Disease Treatment Revenue Share by Region (2012-2017)
Figure United States Wilson's Disease Treatment Revenue Market Share by Region (2012-2017)
Figure United States Wilson's Disease Treatment Revenue Market Share by Region in 2016
Table United States Wilson's Disease Treatment Price (USD/Pcs) by Region (2012-2017)
Table United States Wilson's Disease Treatment Sales (K Pcs) by Type (2012-2017)
Table United States Wilson's Disease Treatment Sales Share by Type (2012-2017)
Figure United States Wilson's Disease Treatment Sales Share by Type (2012-2017)
Figure United States Wilson's Disease Treatment Sales Market Share by Type in 2016
Table United States Wilson's Disease Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Wilson's Disease Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Wilson's Disease Treatment by Type (2012-2017)
Figure Revenue Market Share of Wilson's Disease Treatment by Type in 2016
Table United States Wilson's Disease Treatment Price (USD/Pcs) by Types (2012-2017)
Figure United States Wilson's Disease Treatment Sales Growth Rate by Type (2012-2017)
Table United States Wilson's Disease Treatment Sales (K Pcs) by Application (2012-2017)
Table United States Wilson's Disease Treatment Sales Market Share by Application (2012-2017)
Figure United States Wilson's Disease Treatment Sales Market Share by Application (2012-2017)
Figure United States Wilson's Disease Treatment Sales Market Share by Application in 2016
Table United States Wilson's Disease Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Wilson's Disease Treatment Sales Growth Rate by Application (2012-2017)
Table Valeant Pharmaceuticals International. Inc. Basic Information List
Table Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals International. Inc. Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Tsumura & Co Basic Information List
Table Tsumura & Co Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tsumura & Co Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Tsumura & Co Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Tsumura & Co Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck & Co Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Merck & Co Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Merck & Co Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table VHB Life Science Inc. Basic Information List
Table VHB Life Science Inc. Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure VHB Life Science Inc. Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure VHB Life Science Inc. Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure VHB Life Science Inc. Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceuticals USA, Inc Basic Information List
Table Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceuticals USA, Inc Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Wilson's Therapeutics AB Basic Information List
Table Wilson's Therapeutics AB Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Wilson's Therapeutics AB Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Wilson's Therapeutics AB Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Wilson's Therapeutics AB Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Noble Pharma Co., Ltd Basic Information List
Table Noble Pharma Co., Ltd Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Noble Pharma Co., Ltd Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Noble Pharma Co., Ltd Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Noble Pharma Co., Ltd Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Kadmon Holding, Inc. Basic Information List
Table Kadmon Holding, Inc. Wilson's Disease Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Kadmon Holding, Inc. Wilson's Disease Treatment Sales Growth Rate (2012-2017)
Figure Kadmon Holding, Inc. Wilson's Disease Treatment Sales Market Share in United States (2012-2017)
Figure Kadmon Holding, Inc. Wilson's Disease Treatment Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Wilson's Disease Treatment
Figure Manufacturing Process Analysis of Wilson's Disease Treatment
Figure Wilson's Disease Treatment Industrial Chain Analysis
Table Raw Materials Sources of Wilson's Disease Treatment Major Players/Suppliers in 2016
Table Major Buyers of Wilson's Disease Treatment
Table Distributors/Traders List
Figure United States Wilson's Disease Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Wilson's Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Wilson's Disease Treatment Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Wilson's Disease Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Wilson's Disease Treatment Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Wilson's Disease Treatment Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Wilson's Disease Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Wilson's Disease Treatment Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Wilson's Disease Treatment Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Wilson's Disease Treatment Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Wilson's Disease Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Wilson's Disease Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Wilson's Disease Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources